Bright Minds Biosciences Stock Alpha and Beta Analysis

DRUG Stock  USD 46.55  2.55  5.80%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bright Minds Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bright Minds over a specified time horizon. Remember, high Bright Minds' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bright Minds' market risk premium analysis include:
Beta
(32.22)
Alpha
29
Risk
126.68
Sharpe Ratio
0.15
Expected Return
18.81
Please note that although Bright Minds alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Bright Minds did 29.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Bright Minds Biosciences stock's relative risk over its benchmark. Bright Minds Biosciences has a beta of 32.22  . As returns on the market increase, returns on owning Bright Minds are expected to decrease by larger amounts. On the other hand, during market turmoil, Bright Minds is expected to outperform it. At this time, Bright Minds' Book Value Per Share is most likely to slightly grow in the upcoming years. The Bright Minds' current Tangible Book Value Per Share is estimated to increase to 2.80, while Enterprise Value Over EBITDA is projected to decrease to (0.17).

Enterprise Value

10.39 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Bright Minds Backtesting, Bright Minds Valuation, Bright Minds Correlation, Bright Minds Hype Analysis, Bright Minds Volatility, Bright Minds History and analyze Bright Minds Performance.

Bright Minds Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bright Minds market risk premium is the additional return an investor will receive from holding Bright Minds long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bright Minds. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bright Minds' performance over market.
α29.00   β-32.22

Bright Minds expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bright Minds' Buy-and-hold return. Our buy-and-hold chart shows how Bright Minds performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Bright Minds Market Price Analysis

Market price analysis indicators help investors to evaluate how Bright Minds stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bright Minds shares will generate the highest return on investment. By understating and applying Bright Minds stock market price indicators, traders can identify Bright Minds position entry and exit signals to maximize returns.

Bright Minds Return and Market Media

The median price of Bright Minds for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 21.7 with a coefficient of variation of 98.12. The daily time series for the period is distributed with a sample standard deviation of 21.55, arithmetic mean of 21.96, and mean deviation of 20.77. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Insider Trading
10/15/2024
2
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
10/16/2024
3
Acquisition by Cormorant Asset Management, Lp of 8900 shares of Bright Minds at 7.3052 subject to Rule 16b-3
10/17/2024
4
Whats Going On With Bright Minds Biosciences Stock Friday
10/18/2024
5
Whats Going On With Bright Minds Biosciences Stock
10/21/2024
6
Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona
10/24/2024
7
Cancer Antibody Drug Conjugates Market, Drugs Approval Clinical Trials Report 2024 - A US 50 Billion Market Opportunity By 2030
10/31/2024
8
Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3
11/04/2024
9
Student arrested for trying to sneak meth-soaked T-shirts through LAX in hidden compartment in suitcase
11/13/2024
10
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
11/21/2024
11
Baird assigns Outperform to Bright Minds stock, sees positive readthrough from recent MA
11/26/2024

About Bright Minds Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bright or other stocks. Alpha measures the amount that position in Bright Minds Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
PB Ratio1.391.32
Capex To Depreciation6.2E-55.5E-5

Bright Minds Upcoming Company Events

As portrayed in its financial statements, the presentation of Bright Minds' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bright Minds' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bright Minds' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bright Minds. Please utilize our Beneish M Score to check the likelihood of Bright Minds' management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Bright Minds

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Bright Minds technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bright Minds technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bright Minds trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...